Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.6 USD | -3.76% | +10.19% | +55.15% |
May. 06 | Transcript : Enanta Pharmaceuticals, Inc., Q2 2024 Earnings Call, May 06, 2024 | |
May. 06 | Earnings Flash (ENTA) ENANTA PHARMACEUTICALS Posts Q2 Revenue $17.1M, vs. Street Est of $16.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.15% | 309M | |
+22.81% | 46.81B | |
+46.56% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- ENTA Stock
- News Enanta Pharmaceuticals, Inc.
- Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating